Trial Profile
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 13 Nov 2014
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Macular degeneration; Retinal vein occlusion
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanwa Kagaku Kenkyusho
- 13 Nov 2014 New trial record